Abstract
We are grateful for the critical comments of Thiele et al. because they give us the opportunity to underline the difficulties in applying the current World Health Organization (WHO) classification of thrombocytic myeloproliferative neoplasms and to eliminate potential misunderstandings. 1. The
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.